- Home
- SSRM vs DNLI Comparison
SSRM vs DNLI Comparison
Compare SSRM & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSRM
- DNLI
- Stock Information
- Founded
- SSRM 1946
- DNLI 2013
- Country
- SSRM United States
- DNLI United States
- Employees
- SSRM N/A
- DNLI N/A
- Industry
- SSRM Precious Metals
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SSRM Industrials
- DNLI Health Care
- Exchange
- SSRM Nasdaq
- DNLI Nasdaq
- Market Cap
- SSRM 2.2B
- DNLI 2.1B
- IPO Year
- SSRM 1996
- DNLI 2017
- Fundamental
- Price
- SSRM $12.74
- DNLI $14.47
- Analyst Decision
- SSRM Hold
- DNLI Strong Buy
- Analyst Count
- SSRM 3
- DNLI 15
- Target Price
- SSRM $10.53
- DNLI $33.85
- AVG Volume (30 Days)
- SSRM 2.3M
- DNLI 1.5M
- Earning Date
- SSRM 08-05-2025
- DNLI 08-04-2025
- Dividend Yield
- SSRM N/A
- DNLI N/A
- EPS Growth
- SSRM N/A
- DNLI N/A
- EPS
- SSRM 0.42
- DNLI N/A
- Revenue
- SSRM $1,082,002,000.00
- DNLI N/A
- Revenue This Year
- SSRM $42.12
- DNLI N/A
- Revenue Next Year
- SSRM $21.27
- DNLI $323.34
- P/E Ratio
- SSRM $30.47
- DNLI N/A
- Revenue Growth
- SSRM N/A
- DNLI N/A
- 52 Week Low
- SSRM $4.32
- DNLI $10.57
- 52 Week High
- SSRM $13.48
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- SSRM 53.16
- DNLI 51.07
- Support Level
- SSRM $11.70
- DNLI $13.70
- Resistance Level
- SSRM $13.00
- DNLI $15.15
- Average True Range (ATR)
- SSRM 0.52
- DNLI 0.65
- MACD
- SSRM -0.04
- DNLI -0.06
- Stochastic Oscillator
- SSRM 58.43
- DNLI 45.97
About SSRM SSR Mining Inc.
SSR Mining Inc is a minerals company focused on mining precious metals in the Americas. More than half of Silver Standard's revenue is attributable to the production of gold, with a key portion derived from silver production. The company owns and operates the Marigold mine in Nevada, United States; the Seabee Gold Operation in Saskatchewan, Canada; and the Puna mine in Argentina. The majority of gold production is derived from the Marigold mine, and Silver Standard's silver production is principally derived from the Puna mine.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.